The new clinical trials regulations will result in changes to the approvals process for clinical trials of investigational medicinal products (CTIMPs) in the UK.
These changes will come into force on 28 April 2026 and apply to all CTIMP applications and modifications (currently known as amendments) submitted from this date.
Applications and amendments submitted before this date follow the current process and legislation.
The following pages give you guidance on how the new regulations will change how applications and modifications are processed and approved: